FindTrial
Sign In

A real-world study of GLP-1RA in the treatment of diabetic nephropathy

A real-world study of GLP-1RA in the treatment of diabetic nephropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073482
Enrollment
Unknown
Registered
2023-07-12
Start date
2023-07-15
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

GLP-1RA treatment group:N/A

Sponsors

Sunshine Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 years or older and clinically diagnosed diabetic nephropathy; 2.GLP-1RA treatment for more than 6 months.

Exclusion criteria

Exclusion criteria: 1.Type 1 diabetes.

Design outcomes

Primary

MeasureTime frame
HbA1c;—

Secondary

MeasureTime frame
UACR;Urine A/C;24-hour urine protein quantification;eGFR;—

Countries

China

Contacts

Public ContactYing Liu

Sunshine Union Hospital

175198989@qq.com+86 182 6462 1181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026